A phase Ib study of nivolumab plus trastuzumab with S-1/capecitabine plus oxaliplatin for HER2-positive advanced gastric cancer (Ni-HIGH study): Safety evaluation.
暂无分享，去创建一个
Ken Kato | D. Takahari | N. Boku | K. Minashi | N. Ishizuka | S. Iwasa | K. Yamaguchi | H. Shoji | H. Hirano | H. Hara | M. Ogura | A. Ooki | I. Nakayama | Y. Amanuma | K. Chin